
Sign up to save your podcasts
Or


We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
By Sensible Medicine Authors and Editors4.9
135135 ratings
We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease

32,087 Listeners

4,269 Listeners

1,868 Listeners

542 Listeners

505 Listeners

895 Listeners

2,446 Listeners

3,366 Listeners

1,150 Listeners

8,027 Listeners

755 Listeners

516 Listeners

740 Listeners

442 Listeners

8,442 Listeners